BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34930905)

  • 1. WTIP upregulates FOXO3a and induces apoptosis through PUMA in acute myeloid leukemia.
    Zhu Y; Tong X; Wang Y; Lu X
    Cell Death Dis; 2021 Dec; 13(1):18. PubMed ID: 34930905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WT1-interacting protein inhibits cell proliferation and tumorigenicity in non-small-cell lung cancer via the AKT/FOXO1 axis.
    Wu Z; Qiu M; Mi Z; Meng M; Guo Y; Jiang X; Fang J; Wang H; Zhao J; Liu Z; Qian D; Yuan Z
    Mol Oncol; 2019 May; 13(5):1059-1074. PubMed ID: 30690883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor β upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer.
    Dey P; Ström A; Gustafsson JÅ
    Oncogene; 2014 Aug; 33(33):4213-25. PubMed ID: 24077289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase and murine double minute synergistically induces Apoptosis in acute myeloid leukemia via BH3-only proteins Puma and Bim.
    Zhang W; Konopleva M; Burks JK; Dywer KC; Schober WD; Yang JY; McQueen TJ; Hung MC; Andreeff M
    Cancer Res; 2010 Mar; 70(6):2424-34. PubMed ID: 20215498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia.
    Thépot S; Lainey E; Cluzeau T; Sébert M; Leroy C; Adès L; Tailler M; Galluzzi L; Baran-Marszak F; Roudot H; Eclache V; Gardin C; de Botton S; Auberger P; Fenaux P; Kroemer G; Boehrer S
    Cell Cycle; 2011 Jul; 10(14):2323-30. PubMed ID: 21654193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Betulinic acid derivative B10 inhibits glioma cell proliferation through suppression of SIRT1, acetylation of FOXO3a and upregulation of Bim/PUMA.
    Huo L; Bai X; Wang Y; Wang M
    Biomed Pharmacother; 2017 Aug; 92():347-355. PubMed ID: 28554130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of AKT promotes FOXO3a-dependent apoptosis in prostate cancer.
    Das TP; Suman S; Alatassi H; Ankem MK; Damodaran C
    Cell Death Dis; 2016 Feb; 7(2):e2111. PubMed ID: 26913603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BH3-only protein Bim more critical than Puma in tyrosine kinase inhibitor-induced apoptosis of human leukemic cells and transduced hematopoietic progenitors carrying oncogenic FLT3.
    Nordigården A; Kraft M; Eliasson P; Labi V; Lam EW; Villunger A; Jönsson JI
    Blood; 2009 Mar; 113(10):2302-11. PubMed ID: 19064725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ipatasertib, a novel Akt inhibitor, induces transcription factor FoxO3a and NF-κB directly regulates PUMA-dependent apoptosis.
    Sun L; Huang Y; Liu Y; Zhao Y; He X; Zhang L; Wang F; Zhang Y
    Cell Death Dis; 2018 Sep; 9(9):911. PubMed ID: 30185800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pazopanib, a novel multi-kinase inhibitor, shows potent antitumor activity in colon cancer through PUMA-mediated apoptosis.
    Zhang L; Wang H; Li W; Zhong J; Yu R; Huang X; Wang H; Tan Z; Wang J; Zhang Y
    Oncotarget; 2017 Jan; 8(2):3289-3303. PubMed ID: 27924057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copanlisib promotes growth inhibition and apoptosis by modulating the AKT/FoxO3a/PUMA axis in colorectal cancer.
    Yan J; Yang S; Tian H; Zhang Y; Zhao H
    Cell Death Dis; 2020 Nov; 11(11):943. PubMed ID: 33139695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO-dependent mechanism.
    Kelly KR; Nawrocki ST; Espitia CM; Zhang M; Yang JJ; Padmanabhan S; Ecsedy J; Giles FJ; Carew JS
    Int J Cancer; 2012 Dec; 131(11):2693-703. PubMed ID: 22488249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the UBA2-WTIP fusion gene in acute myeloid leukemia.
    Lu X; Zhuang H; Yu Q; Zhang X; Wu Z; Zhang L; Xu Y; Wu B; Yang L; Ma A; Gan X; Yu X; Shen J; Xu R
    Exp Cell Res; 2018 Oct; 371(2):409-416. PubMed ID: 30179602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. U2AF1 mutation promotes tumorigenicity through facilitating autophagy flux mediated by FOXO3a activation in myelodysplastic syndromes.
    Zhu Y; Song D; Guo J; Jin J; Tao Y; Zhang Z; Xu F; He Q; Li X; Chang C; Wu L
    Cell Death Dis; 2021 Jun; 12(7):655. PubMed ID: 34183647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-183-5p Inhibits Occurrence and Progression of Acute Myeloid Leukemia via Targeting Erbin.
    Zheng Z; Zheng X; Zhu Y; Gu X; Gu W; Xie X; Hu W; Jiang J
    Mol Ther; 2019 Mar; 27(3):542-558. PubMed ID: 30799283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-20a-5p functions as a potent tumor suppressor by targeting PPP6C in acute myeloid leukemia.
    Bao F; Zhang L; Pei X; Lian C; Liu Y; Tan H; Lei P
    PLoS One; 2021; 16(9):e0256995. PubMed ID: 34587164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pterocarpanquinone LQB-118 induces apoptosis in acute myeloid leukemia cells of distinct molecular subtypes and targets FoxO3a and FoxM1 transcription factors.
    Nestal de Moraes G; Castro CP; Salustiano EJ; Dumas ML; Costas F; Lam EW; Costa PR; Maia RC
    Int J Oncol; 2014 Nov; 45(5):1949-58. PubMed ID: 25174716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitavastatin induces apoptosis in oral squamous cell carcinoma through activation of FOXO3a.
    Lee N; Tilija Pun N; Jang WJ; Bae JW; Jeong CH
    J Cell Mol Med; 2020 Jun; 24(12):7055-7066. PubMed ID: 32406610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cordycepin induces apoptosis by caveolin-1-mediated JNK regulation of Foxo3a in human lung adenocarcinoma.
    Joo JC; Hwang JH; Jo E; Kim YR; Kim DJ; Lee KB; Park SJ; Jang IS
    Oncotarget; 2017 Feb; 8(7):12211-12224. PubMed ID: 28099944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLZF regulates apoptosis of leukemia cells by regulating AKT/Foxo3a pathway.
    Li JX; Zhang ZF; Wang XB; Yang EQ; Dong L; Meng J
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6411-6418. PubMed ID: 31378879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.